Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

291
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
291
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

307
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
307
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

302
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
302
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

307
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
307

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Danger of very high HDL levels.

Bratislavske lekarske listy·2017
Same author

Deficiency of vitamin D and vitamin C in the pathogenesis of bronchial asthma.

Bratislavske lekarske listy·2016
Same author

New data on harmful effects of trans-fatty acids.

Bratislavske lekarske listy·2016
Same author

How far down to push the LDL cholesterol? PCSK9 where statins fail.

Bratislavske lekarske listy·2016
Same author

Region-specific differences in colorectal cancer: Slovakia and Hungary have highest incidence in Europe.

Bratislavske lekarske listy·2016
Same author

Novel potential for the management of Alzheimer disease.

Bratislavske lekarske listy·2015

Related Experiment Video

Updated: Mar 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Risk of statin therapy in elderly.

E Ginter, I Kajaba

    Bratislavske Lekarske Listy
    |November 10, 2016
    PubMed
    Summary

    Statins effectively reduce vascular events and mortality in individuals with high cholesterol and coronary heart disease risk. However, their use in the elderly may cause significant side effects despite disease prevention benefits.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Preventive Medicine

    Background:

    • High cholesterol and coronary heart disease (CHD) are significant global health concerns.
    • Statins are widely prescribed lipid-lowering medications.
    • Evidence regarding statin efficacy and safety across different age groups requires synthesis.

    Purpose of the Study:

    • To evaluate the effectiveness of statin therapy in reducing vascular events and mortality.
    • To assess the benefits and risks of statin use in younger patients versus the elderly.

    Main Methods:

    • A meta-analysis was conducted on randomized controlled trials.
    • The analysis focused on outcomes in patients with high cholesterol and CHD risk.
    • Subgroup analyses considered patient age.

    Related Experiment Videos

    Last Updated: Mar 12, 2026

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    15.2K

    Main Results:

    • Statins demonstrated a significant reduction in vascular events and mortality in younger patients with high cholesterol and CHD risk.
    • In the elderly, statins were found to prevent disease but were associated with considerable side effects.

    Conclusions:

    • Statin therapy is beneficial for preventing vascular events and mortality in younger individuals with elevated cholesterol and CHD risk.
    • The use of statins in the elderly necessitates careful consideration of potential side effects alongside preventive benefits.